Fair value (multi-method)
Four independent methods triangulate what CLX is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$89.61
Method range
$12.57 – $193.80
median $97.55
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $89.61 | -4.82% |
| Exit multiple | $193.80 | +105.86% |
| Analyst target | $105.50 | +12.07% |
| Graham number | $12.57 | -86.65% |
- Forward DCF$89.61
- Exit multiple$193.80
- Analyst target$105.50
- Graham number$12.57
Stock price
$94.14
EPS (TTM)
$6.16
5Y EPS CAGR
-2.4%
Fair value @ hist. growth
$89.61
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied EPS growth
-1.7%
per year over your projection horizon
Margin of safety -5.1% vs hist-growth DCF
Historical 5Y CAGR
-2.4%
Your model implies
-1.7%
Next-year analyst consensus
-10.2%
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.3% | -5.2% | -6.3% | -7.6% | -9.1% | -11.0% |
| 6.3% | -2.6% | -3.4% | -4.4% | -5.5% | -6.8% |
| 7.3% | -0.3% | -1.0% | -1.7% | -2.6% | -3.6% |
| 8.3% | 1.8% | 1.2% | 0.6% | -0.1% | -0.9% |
| 9.3% | 3.7% | 3.2% | 2.6% | 2.1% | 1.4% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.87
Low vs growth
Net debt
$2.7B
Total debt − cash
Beta
0.55
Vs market benchmark
Annual diluted EPS
Per-share earnings by fiscal year — last 5 years anchor the CAGR reference above.
Frequently asked questions
Clorox (CLX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation